Found: 46
Select item for more details and to access through your institution.
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.
- Published in:
- PLoS Medicine, 2024, v. 21, n. 5, p. 1, doi. 10.1371/journal.pmed.1004389
- By:
- Publication type:
- Article
Efficacy and safety of modified FOLFIRINOX as salvage therapy for patients with refractory advanced biliary tract cancer: a retrospective study.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 3, p. 836, doi. 10.1007/s10637-020-01045-7
- By:
- Publication type:
- Article
Recombinant human endostatin plus paclitaxel/nedaplatin for recurrent or metastatic advanced esophageal squamous cell carcinoma: a prospective, single-arm, open-label, phase II study.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 2, p. 516, doi. 10.1007/s10637-020-01021-1
- By:
- Publication type:
- Article
ARRY-334543 Reverses Multidrug Resistance by Antagonizing the Activity of ATP-Binding Cassette Subfamily G Member 2.
- Published in:
- Journal of Cellular Biochemistry, 2014, v. 115, n. 8, p. 1381, doi. 10.1002/jcb.24787
- By:
- Publication type:
- Article
Expert opinions on immunotherapy for patients with colorectal cancer.
- Published in:
- Cancer Communications, 2020, v. 40, n. 10, p. 467, doi. 10.1002/cac2.12095
- By:
- Publication type:
- Article
A plasma cytokine and angiogenic factor (CAF) analysis for selection of bevacizumab therapy in patients with metastatic colorectal cancer.
- Published in:
- Scientific Reports, 2015, v. 5, n. 1, p. 17717, doi. 10.1038/srep17717
- By:
- Publication type:
- Article
Retraction Note: Suppression of fumarate hydratase activity increases the efficacy of cisplatin-mediated chemotherapy in gastric cancer.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41419-023-05604-7
- By:
- Publication type:
- Article
Suppression of fumarate hydratase activity increases the efficacy of cisplatin-mediated chemotherapy in gastric cancer.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 6, p. N.PAG, doi. 10.1038/s41419-019-1652-8
- By:
- Publication type:
- Article
LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer.
- Published in:
- Molecular Cancer, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12943-019-1105-0
- By:
- Publication type:
- Article
Exploring ALK fusion in colorectal cancer: a case series and comprehensive analysis.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00598-7
- By:
- Publication type:
- Article
VDR–SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment.
- Published in:
- Signal Transduction & Targeted Therapy, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41392-020-00230-7
- By:
- Publication type:
- Article
Clinical and molecular characteristics of RNF43 mutations as promising prognostic biomarkers in colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359231220600
- By:
- Publication type:
- Article
ASO Visual Abstract: A 3-Year Survival Update From a Phase II Study of Paclitaxel Plus Cisplatin and 5-Fluorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical Trial.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
A 3-Year Survival Update from a Phase 2 Study of Paclitaxel Plus Cisplatin and 5-Fuorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical Trial.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 2, p. 838, doi. 10.1245/s10434-023-14513-0
- By:
- Publication type:
- Article
ASO Visual Abstract: Circulating Lipid- and Inflammation-Based Risk (CLIR) Score—A Promising New Model for Predicting Outcomes in Complete Colorectal Liver Metastases Resection.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Circulating Lipid- and Inflammation-Based Risk (CLIR) Score: A Promising New Model for Predicting Outcomes in Complete Colorectal Liver Metastases Resection.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 7, p. 4308, doi. 10.1245/s10434-021-11234-0
- By:
- Publication type:
- Article
Circular RNA: metabolism, functions and interactions with proteins.
- Published in:
- Molecular Cancer, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12943-020-01286-3
- By:
- Publication type:
- Article
Heterogeneity and evolution of tumour immune microenvironment in metastatic gastroesophageal adenocarcinoma.
- Published in:
- Gastric Cancer, 2022, v. 25, n. 6, p. 1017, doi. 10.1007/s10120-022-01324-7
- By:
- Publication type:
- Article
Modulation of Redox Homeostasis by Inhibition of MTHFD2 in Colorectal Cancer: Mechanisms and Therapeutic Implications.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction to: Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 12, p. 2413, doi. 10.1007/s00432-017-2493-4
- By:
- Publication type:
- Article
Phase III randomized, placebo‐controlled, double‐blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin‐induced peripheral neurotoxicity in stage II/III colorectal cancer.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 1, p. 151, doi. 10.1002/cam4.2693
- By:
- Publication type:
- Article
Correlation between immune signature and high‐density lipoprotein cholesterol level in stage II/III colorectal cancer.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 3, p. 1209, doi. 10.1002/cam4.1987
- By:
- Publication type:
- Article
Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER‐based study.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 8, p. 3662, doi. 10.1002/cam4.1661
- By:
- Publication type:
- Article
Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China.
- Published in:
- Journal of Translational Medicine, 2012, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-58
- By:
- Publication type:
- Article
The Prognostic Value of Locoregional Interventions for BRAF V600E Metastatic Colorectal Cancer: A Retrospective Cohort Analysis.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 9, p. 1268, doi. 10.3390/biom11091268
- By:
- Publication type:
- Article
Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.
- Published in:
- Carcinogenesis, 2013, v. 34, n. 4, p. 803, doi. 10.1093/carcin/bgs400
- By:
- Publication type:
- Article
Baseline lesion number as an efficacy predictive and independent prognostic factor and its joint utility with TMB for PD-1 inhibitor treatment in advanced gastric cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921988996
- By:
- Publication type:
- Article
Baseline lesion number as an efficacy predictive and independent prognostic factor and its joint utility with TMB for PD-1 inhibitor treatment in advanced gastric cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835921988996
- By:
- Publication type:
- Article
The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative‐intent hepatectomy for colorectal liver metastases: A two‐center cohort study.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 22, p. 8005, doi. 10.1002/cam4.4315
- By:
- Publication type:
- Article
A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 5, p. 1535, doi. 10.1002/cam4.3697
- By:
- Publication type:
- Article
Prognostic relevance of BRD7 expression in colorectal carcinoma.
- Published in:
- European Journal of Clinical Investigation, 2013, v. 43, n. 2, p. 131, doi. 10.1111/eci.12024
- By:
- Publication type:
- Article
Clinical outcomes of Chinese patients with metastatic colorectal cancer receiving first-line bevacizumab-containing treatment.
- Published in:
- Medical Oncology, 2015, v. 32, n. 2, p. 1, doi. 10.1007/s12032-014-0469-7
- By:
- Publication type:
- Article
Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer.
- Published in:
- Medical Oncology, 2012, v. 29, n. 5, p. 3092, doi. 10.1007/s12032-012-0226-8
- By:
- Publication type:
- Article
Histopathological growth patterns correlate with the immunoscore in colorectal cancer liver metastasis patients after hepatectomy.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 12, p. 2623, doi. 10.1007/s00262-020-02632-6
- By:
- Publication type:
- Article
Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15112-3
- By:
- Publication type:
- Article
Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 4, p. 1065, doi. 10.1007/s00280-013-2102-4
- By:
- Publication type:
- Article
Effect of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Women: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 4, p. e215250, doi. 10.1001/jamanetworkopen.2021.5250
- By:
- Publication type:
- Article
Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
HER2-positive patients receiving trastuzumab treatment have a comparable prognosis with HER2-negative advanced gastric cancer patients: A prospective cohort observation.
- Published in:
- International Journal of Cancer, 2014, v. 134, n. 10, p. 2468, doi. 10.1002/ijc.28559
- By:
- Publication type:
- Article
ABO blood group, hepatitis B viral infection and risk of pancreatic cancer.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 2, p. 461, doi. 10.1002/ijc.26376
- By:
- Publication type:
- Article
Methylated ctDNA predicts early recurrence risk in patients undergoing resection of initially unresectable colorectal cancer liver metastases.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241230752
- By:
- Publication type:
- Article